Context Therapeutics Inc. (CNTX) Tops Q1 EPS by 9c
Get Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q1 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xos, Inc (XOS) Tops Q2 EPS by 5c
- Shotspotter (SSTI) Misses Q2 EPS by 19c; Offers Guidance
- StoneCo (STNE) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share